Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber/Boston Children’s Cancer and Blood Disorders Center has a five-year cancer survival rate of 87.5 percent for all cancer types, ahead of the national benchmark of 82.8 percent, according data from the National Cancer Institute. The center includes the Advancing Childhood Cancer Therapies Clinic for pediatric research and care for patients with relapsed, refractory or recurrent cancer. U.S. News & World Report ranked the center as the No. 2 pediatric cancer center in the country for 2017-18.
 |
RETURN TO FULL LIST |  |
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
